Current and historical daily PE Ratio for CK Life Sciences International Holdings Inc (
) from 2002 to May 20 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. CK Life Sciences International stock (HKSE:00775) PE ratio as of May 20 2024 is 210.
More Details
CK Life Sciences International Holdings Inc (HKSE:00775) PE Ratio (TTM) Chart
CK Life Sciences International Holdings Inc (HKSE:00775) PE Ratio (TTM) Historical Data
View and export this data going back to 2002. Start your Free Trial
Total 1208
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| CK Life Sciences International PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-21 | 210.0 | 2024-03-12 | 215.0 |
| 2024-05-20 | 210.0 | 2024-03-11 | 212.5 |
| 2024-05-17 | 222.5 | 2024-03-08 | 212.5 |
| 2024-05-16 | 227.5 | 2024-03-07 | 205.0 |
| 2024-05-14 | 225.0 | 2024-03-06 | 210.0 |
| 2024-05-13 | 225.0 | 2024-03-05 | 215.0 |
| 2024-05-10 | 227.5 | 2024-03-04 | 230.0 |
| 2024-05-09 | 225.0 | 2024-03-01 | 240.0 |
| 2024-05-08 | 212.5 | 2024-02-29 | 237.5 |
| 2024-05-07 | 217.5 | 2024-02-28 | 250.0 |
| 2024-05-06 | 227.5 | 2024-02-27 | 275.0 |
| 2024-05-03 | 205.0 | 2024-02-26 | 270.0 |
| 2024-05-02 | 197.5 | 2024-02-23 | 270.0 |
| 2024-04-30 | 187.5 | 2024-02-22 | 260.0 |
| 2024-04-29 | 182.5 | 2024-02-21 | 265.0 |
| 2024-04-26 | 172.5 | 2024-02-20 | 265.0 |
| 2024-04-25 | 170.0 | 2024-02-19 | 270.0 |
| 2024-04-24 | 172.5 | 2024-02-16 | 275.0 |
| 2024-04-23 | 167.5 | 2024-02-15 | 260.0 |
| 2024-04-22 | 170.0 | 2024-02-14 | 270.0 |
| 2024-04-19 | 167.5 | 2024-02-09 | 270.0 |
| 2024-04-18 | 170.0 | 2024-02-08 | 275.0 |
| 2024-04-17 | 170.0 | 2024-02-07 | 260.0 |
| 2024-04-16 | 170.0 | 2024-02-06 | 260.0 |
| 2024-04-15 | 175.0 | 2024-02-05 | 255.0 |
| 2024-04-12 | 182.5 | 2024-02-02 | 260.0 |
| 2024-04-11 | 195.0 | 2024-02-01 | 265.0 |
| 2024-04-10 | 190.0 | 2024-01-31 | 265.0 |
| 2024-04-09 | 190.0 | 2024-01-30 | 280.0 |
| 2024-04-08 | 192.5 | 2024-01-29 | 290.0 |
| 2024-04-05 | 160.0 | 2024-01-26 | 290.0 |
| 2024-04-03 | 155.0 | 2024-01-25 | 290.0 |
| 2024-04-02 | 160.0 | 2024-01-24 | 285.0 |
| 2024-03-28 | 167.5 | 2024-01-23 | 280.0 |
| 2024-03-27 | 172.5 | 2024-01-22 | 280.0 |
| 2024-03-26 | 180.0 | 2024-01-19 | 290.0 |
| 2024-03-25 | 185.0 | 2024-01-18 | 285.0 |
| 2024-03-22 | 192.5 | 2024-01-17 | 285.0 |
| 2024-03-21 | 200.0 | 2024-01-16 | 295.0 |
| 2024-03-20 | 200.0 | 2024-01-15 | 300.0 |
| 2024-03-19 | 202.5 | 2024-01-12 | 300.0 |
| 2024-03-18 | 200.0 | 2024-01-11 | 300.0 |
| 2024-03-15 | 205.0 | 2024-01-10 | 295.0 |
| 2024-03-14 | 212.5 | 2024-01-09 | 295.0 |
| 2024-03-13 | 210.0 | 2024-01-08 | 300.0 |
CK Life Sciences International Holdings Inc (HKSE:00775) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
CK Life Sciences International Holdings Inc
NAICS : 541711
ISIN : KYG2176J1058
Compare
Compare
Traded in other countries / regions
00775.Hong KongLSI.Germany IPO Date
2002-07-16Description
CK Life Sciences International Holdings Inc is a biotechnology company engaged in the research & development, commercialization, and sale of health and agricultural-related products. Products developed by CK Life Sciences are categorized into the areas of human health and environmental sustainability. The operating segments of the company are Agriculture-related and Health. The company derives maximum revenue from the health segment. The overall product portfolio of the company involves a presence that spans North America and the Asia Pacific.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers